Paulina Daniela Ramirez Garcia

Dr. Paulina Daniela Ramirez Garcia

New York University, New York, USA
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2019 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
Paulina Daniela Ramirez GarciaPaulina Daniela Ramirez Garcia
Paulina Daniela Ramirez Garcia
JRJeffri S. Retamal
Jeffri S. Retamal
PSPriyank Shenoy
Priyank Shenoy
WIWendy Imlach
Wendy Imlach
MSMatthew Sykes
Matthew Sykes
NBNigel W. Bunnett
Nigel W. Bunnett

3 February 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
FLFrancesco De Logu
Francesco De Logu
RNRomina Nassini
Romina Nassini
AHAlan Hegron
Alan Hegron
LLLorenzo Landini
Lorenzo Landini
DJDane D Jensen
Dane D Jensen
PGPierangelo Geppetti
Pierangelo Geppetti
Efficacy of monoclonal antibodies against calcitonin gene-related peptide (CGRP) or its receptor (calcitonin receptor-like receptor/receptor activity modifying protein-1, CLR/RAMP1) implicates peripherally-released CGRP in migraine pain. However, the site and mechanism of CGRP-evoked peripheral pain remain unclear. By cell-selective RAMP1 gene deletion, we reveal that CGRP released from mouse cutaneous trigeminal fibers targets CLR/RAMP1 on surrounding Schwann cells to evoke periorbital mechanical allodynia. CLR/RAMP1 activation in human and mouse Schwann cells generates long-lasting signals from endosomes that evoke cAMP-dependent formation of NO. NO, by gating Schwann cell transient receptor potential ankyrin 1 (TRPA1), releases ROS, which in a feed-forward manner sustain allodynia via nociceptor TRPA1. When encapsulated into nanoparticles that release cargo in acidified endosomes, a CLR/RAMP1 antagonist provides superior inhibition of CGRP signaling and allodynia in mice. Our data suggest that the CGRP-mediated neuronal/Schwann cell pathway mediates allodynia associated with neurogenic inflammation, contributing to the algesic action of CGRP in mice.

11 October 2018 in Biomacromolecules
Verified
Journal Article
Closed access
Ruirui QiaoRuirui Qiao
Ruirui Qiao
LELars Esser
Lars Esser
CFChangkui Fu
Changkui Fu
Cheng ZhangCheng Zhang
Cheng Zhang
Jinming HuJinming Hu
Jinming Hu
TDThomas Davis
Thomas Davis

28 April 2022 in Biomaterials
Verified
Journal Article
Closed access
RLRocco Latorre
Rocco Latorre
Paulina Daniela Ramirez GarciaPaulina Daniela Ramirez Garcia
Paulina Daniela Ramirez Garcia
AHAlan Hegron
Alan Hegron
JGJames L. Grace
James L. Grace
JRJeffri S. Retamal
Jeffri S. Retamal
NBNigel W. Bunnett
Nigel W. Bunnett

12 November 2019 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
PDF file
JRJeffri S. Retamal
Jeffri S. Retamal
Paulina Daniela Ramirez GarciaPaulina Daniela Ramirez Garcia
Paulina Daniela Ramirez Garcia
PSPriyank A. Shenoy
Priyank A. Shenoy
DPDaniel P. Poole
Daniel P. Poole
NVNicholas A. Veldhuis
Nicholas A. Veldhuis
Peripheral and central neurons in the pain pathway are well equipped to detect and respond to extracellular stimuli such as pro-inflammatory mediators and neurotransmitters through the cell surface expression of receptors that can mediate rapid intracellular signaling. Following injury or infection, activation of cell surface G protein-coupled receptors (GPCRs) initiates cell signaling processes that lead to the generation of action potentials in neurons or inflammatory responses such as cytokine secretion by immune cells. However, it is now appreciated that cell surface events alone may not be sufficient for all receptors to generate their complete signaling repertoire. Following an initial wave of signaling at the cell surface, active GPCRs can engage with endocytic proteins such as the adaptor protein β-arrestin (βArr) to promote clathrin-mediated internalization. Classically, βArr-mediated internalization of GPCRs was hypothesized to terminate signaling, yet for multiple GPCRs known to contribute to pain, it has been demonstrated that endocytosis can also promote a unique “second wave” of signaling from intracellular membranes, including those of endosomes and the Golgi, that is spatiotemporally distinct from initial cell-surface events. In the context of pain, understanding the cellular and molecular mechanisms that drive spatiotemporal signaling of GPCRs is invaluable for understanding how pain occurs and persists, and how current analgesics achieve efficacy or promote side-effects. This review article discusses the importance of receptor localization for signaling outcomes of pro- and anti-nociceptive GPCRs, and new analgesic opportunities emerging through the development of “location-biased” ligands that favor binding with intracellular GPCR populations.

20 January 2020 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
YAYassamin N. Albayaty
Yassamin N. Albayaty
NTNicky Thomas
Nicky Thomas
Paulina Daniela Ramirez GarciaPaulina Daniela Ramirez Garcia
Paulina Daniela Ramirez Garcia
TDThomas P. Davis
Thomas P. Davis
JQJohn F. Quinn
John F. Quinn
Clive PrestidgeClive Prestidge
Clive Prestidge
Candida albicans (C. albicans) is a common fungal pathogen causing both localised and systemic infections. The majority of these infections are promoted by biofilm formation, providing a protective matrix for the embedded fungi thereby evading the host immune defence and promoting resistance against anti-mycotic agents. In this study, pH-responsive micellar systems based on poly-(ethylene glycol) ethyl ether methacrylate (PEGMA) and poly 2-(diethylamino) ethyl methacrylate (DEAEMA) block-copolymers of P(PEGMA-b-DEAEMA) were specifically developed and loaded with the antifungal itraconazole (ICZ) to defeat C. albicans biofilms. The P(PEGMA-b-DEAEMA) di-block polymer micelles demonstrated a particle size of 55 ± 6 nm and high ICZ loads (12.0 ± 0.5% w/w). Within the biofilm's acidic microenvironment, tertiary amines of the pH-sensitive DEAEMA block are protonated, altering their conformation and enhancing the release of the micellar contents. Encapsulation of ICZ within micelles significantly enhanced the activity against C. albicans biofilms, with a significant reduction in the biofilm biomass (>50%) and in the number of viable cells (2.4 Log reduction) achieved, compared with the non-encapsulated ICZ. Confocal microscopy revealed a high affinity and accumulation of the micelles in C. albicans biofilms as a result of their size and specific electrostatic interaction, hence their improved activity. P(PEGMA-b-DEAEMA) based pH-responsive micelles offer significant potential as antifungal carriers for controlling Candida infections.